Denmark-based Novo Nordisk, which makes Ozempic, Rybelsus and Wegovy; and Indianapolis-based Eli Lilly, which makes Zepbound, ...

The Trump administration announced its newest pharmaceutical agreement under its Most Favored Nation policy Thursday, ...

Novo Nordisk said on Wednesday it has accepted the U.S. Inflation Reduction Act (IRA)'s maximum fair price for its diabetes ...

Such conversations are becoming increasingly common as demand for weight-loss drugs explodes in urban India - a country with ...

The FDA has approved Rybelsus® to reduce the risk of MACE in adults with T2DM who are at high risk for these events.

Rybelsus is now FDA-approved for managing cardiovascular health. Doctors say oral GLP-1s may reduce heart attack and stroke ...

This article was reviewed by Darragh O’Carroll, MD. Oral vs. Injectable Semaglutide: Effectiveness & Side Effects Key takeaways: You can get semaglutide injections (Ozempic® and Wegovy®) ...

Novo Nordisk's Rybelsus gets US FDA approval for CV risk reduction in adults with type 2 diabetes who are at high risk, including those who have not had a prior CV event: Plainsbo ...

There are two diabetes medications that are also used for weight loss – Rybelsus and Ozempic. They both contain the same drug called Semaglutide, Rybelsus is an oral medication whereas Ozempic is an ...

What Is Rybelsus, and Why Does It Matter? Rybelsus (semaglutide) is a once-daily pill used to help lower blood sugar in adults with type 2 diabetes (T2D). It belongs to a group of medicines called GLP ...

The 72-week multinational phase 3 ATTAIN-2 trial randomized 1613 participants with obesity or overweight (BMI ≥ 27.0) and T2D ...

Rybelsus (semaglutide) has now been approved it for use by adults with type 2 diabetes who have high risk of major adverse cardiovascular events (MACE) such as cardiovascular (CV) death, heart attack ...